Home » Topics » BioWorld Science

BioWorld Science
RSS

AU-007 shows promising anticancer activity in murine models

March 22, 2022

Philochem and Bracco Imaging collaborate on small molecule for imaging applications

March 22, 2022

iTolerance raises financing to advance preclinical programs based on iTOL-100 platform technology

March 22, 2022

Chimeron to use NIAID preclinical services program for COVID-19 vaccine candidate

March 22, 2022

IRLAB to advance IRL-757 for apathy in neurodegenerative disorders

March 22, 2022

RNAGene and PharmAbcine collaborate to develop next-generation mRNA-based antibody therapeutics

March 22, 2022

In vivo data show Evusheld retains neutralizing activity against Omicron SARS-CoV-2 BA.2 subvariant

March 22, 2022

Targeting ART1 improves tumor control in NSCLC

March 22, 2022

ASK1 inhibition for the treatment of neuroinflammation, stroke and ALS

March 22, 2022

Targeting HIF-1alpha/CXCR4 axis as therapeutic strategy in ESCC

March 22, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...